Selected references

  1. Balasubramanyam A, Coraza I, Smith EO, et al. Combination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial. J.Clin.Endocrinol.Metab 2011;96(7):2236-2247.
  2. Betteridge DJ. Lipid control in patients with diabetes mellitus. Nat.Rev.Cardiol. 2011;8(5):278-290.
  3. Boden WE, Probstfield JL, Anderson T, et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N.Engl.J.Med. 12-15-2011;365(24):2255-2267.
  4. Chapman MJ, Redfern JS, McGovern ME, et al. Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk. Pharmacol.Ther. 2010;126(3):314-345.
  5. Daniels SE, Spivey RJ, Singla S, et al. Efficacy and safety of oxycodone HCl/niacin tablets for the treatment of moderate-to-severe postoperative pain following bunionectomy surgery. Curr.Med.Res.Opin. 2011;27(3):593-603.
  6. Dunatchik AP, Ito MK, and Dujovne CA. A systematic review on evidence of the effectiveness and safety of a wax-matrix niacin formulation. J.Clin.Lipidol. 2012;6(2):121-131.
  7. Henriquez-Sanchez P, Sanchez-Villegas A, Doreste-Alonso J, et al. Dietary assessment methods for micronutrient intake: a systematic review on vitamins. Br.J.Nutr. 2009;102 Suppl 1:S10-S37.
  8. Ito MK. Dyslipidemia: management using optimal lipid-lowering therapy. Ann.Pharmacother. 2012;46(10):1368-1381.
  9. Ng CF, Lee CP, Ho AL, et al. Effect of niacin on erectile function in men suffering erectile dysfunction and dyslipidemia. J.Sex Med. 2011;8(10):2883-2893.
  10. Orr KK and Hume AL. An evidence-based update on vitamins. Med.Health R.I. 2010;93(4):122-124.
  11. Prasad V and Vandross A. Cardiovascular primary prevention: how high should we set the bar? Arch.Intern.Med. 4-23-2012;172(8):656-659.
  12. Robinson JG, Wang S, and Jacobson TA. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am.J.Cardiol. 11-15-2012;110(10):1468-1476.
  13. Shaikh Q and Kamal AK. HDL cholesterol--how do I raise my patients good cholesterol? J.Pak.Med.Assoc. 2012;62(6):623-624.
  14. Troesch B, Hoeft B, McBurney M, et al. Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries. Br.J.Nutr. 2012;108(4):692-698.
  15. Yadav R, France M, Younis N, et al. Extended-release niacin with laropiprant : a review on efficacy, clinical effectiveness and safety. Expert.Opin.Pharmacother. 2012;13(9):1345-1362.

This evidence-based monograph was prepared by The Natural Standard Research Collaboration